Citigroup
PTCT icon

Citigroup’s PTC Therapeutics PTCT Stock Holding History

Citigroup’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68M Buy
118,656
+96,510
+436% +$6.97M ﹤0.01% 1645
2026
Q1 		$1.51M Sell
22,146
-10,515
-32% -$745K ﹤0.01% 2850
2025
Q4 		$2.48M Buy
32,661
+18,275
+127% +$1.33M ﹤0.01% 2518
2025
Q3 		$883K Sell
14,386
-274,150
-95% -$14.3M ﹤0.01% 3244
2025
Q2 		$14.1M Sell
288,536
-17,281
-6% -$820K 0.01% 1169
2025
Q1 		$15.6M Buy
305,817
+206,653
+208% +$10.3M 0.01% 1099
2024
Q4 		$4.48M Buy
99,164
+41,859
+73% +$1.79M ﹤0.01% 2083
2024
Q3 		$2.13M Buy
57,305
+25,722
+81% +$861K ﹤0.01% 2610
2024
Q2 		$966K Sell
31,583
-306,216
-91% -$9.92M ﹤0.01% 2945
2024
Q1 		$9.83M Buy
337,799
+122,816
+57% +$3.44M 0.01% 1264
2023
Q4 		$5.92M Buy
214,983
+7,865
+4% +$180K ﹤0.01% 1476
2023
Q3 		$4.64M Buy
207,118
+116,800
+129% +$4.34M ﹤0.01% 1472
2023
Q2 		$3.67M Sell
90,318
-35,827
-28% -$1.75M ﹤0.01% 1703
2023
Q1 		$6.11M Buy
126,145
+25,797
+26% +$1.18M ﹤0.01% 1389
2022
Q4 		$3.83M Sell
100,348
-22,110
-18% -$919K ﹤0.01% 1618
2022
Q3 		$6.15M Sell
122,458
-5,647
-4% -$277K ﹤0.01% 1431
2022
Q2 		$5.13M Buy
128,105
+90,989
+245% +$3.19M ﹤0.01% 1523
2022
Q1 		$1.39M Sell
37,116
-95,752
-72% -$3.69M ﹤0.01% 2663
2021
Q4 		$5.29M Buy
132,868
+57,012
+75% +$2.18M ﹤0.01% 1784
2021
Q3 		$2.82M Sell
75,856
-45,210
-37% -$1.86M ﹤0.01% 2253
2021
Q2 		$5.12M Buy
121,066
+40,661
+51% +$1.74M ﹤0.01% 1875
2021
Q1 		$3.81M Buy
80,405
+57,573
+252% +$3.42M ﹤0.01% 1997
2020
Q4 		$1.39M Sell
22,832
-11,476
-33% -$676K ﹤0.01% 3217
2020
Q3 		$1.6M Sell
34,308
-28,861
-46% -$1.42M ﹤0.01% 2856
2020
Q2 		$3.21M Sell
63,169
-2,729
-4% -$134K ﹤0.01% 2293
2020
Q1 		$2.94M Buy
65,898
+27,059
+70% +$1.36M ﹤0.01% 2122
2019
Q4 		$1.87M Sell
38,839
-13,478
-26% -$573K ﹤0.01% 3063
2019
Q3 		$1.77M Buy
52,317
+49,795
+1,974% +$2.17M ﹤0.01% 3007
2019
Q2 		$113K Sell
2,522
-280,551
-99% -$11.1M ﹤0.01% 5753
2019
Q1 		$10.7M Buy
283,073
+103,870
+58% +$3.49M 0.01% 1226
2018
Q4 		$6.15M Buy
179,203
+174,065
+3,388% +$6.26M 0.01% 1648
2018
Q3 		$241K Sell
5,138
-434
-8% -$18K ﹤0.01% 5056
2018
Q2 		$188K Sell
5,572
-471,174
-99% -$14.7M ﹤0.01% 5132
2018
Q1 		$12.9M Buy
476,746
+372,506
+357% +$9.44M 0.01% 1066
2017
Q4 		$1.74M Buy
104,240
+63,772
+158% +$1.08M ﹤0.01% 2818
2017
Q3 		$810K Sell
40,468
-5,470
-12% -$107K ﹤0.01% 3600
2017
Q2 		$842K Buy
45,938
+16,307
+55% +$220K ﹤0.01% 3492
2017
Q1 		$292K Sell
29,631
-24,732
-45% -$299K ﹤0.01% 4333
2016
Q4 		$593K Buy
54,363
+43,981
+424% +$461K ﹤0.01% 4201
2016
Q3 		$145K Sell
10,382
-5,243
-34% -$42.6K ﹤0.01% 4923
2016
Q2 		$109K Sell
15,625
-21,687
-58% -$159K ﹤0.01% 5009
2016
Q1 		$240K Buy
37,312
+21,535
+136% +$374K ﹤0.01% 4907
2015
Q4 		$511K Sell
15,777
-40,924
-72% -$1.2M ﹤0.01% 3843
2015
Q3 		$1.51M Buy
56,701
+45,979
+429% +$1.97M ﹤0.01% 2702
2015
Q2 		$516K Sell
10,722
-1,470
-12% -$85.8K ﹤0.01% 3675
2015
Q1 		$742K Sell
12,192
-3,577
-23% -$218K ﹤0.01% 3356
2014
Q4 		$816K Buy
15,769
+10,492
+199% +$462K ﹤0.01% 3350
2014
Q3 		$232K Sell
5,277
-1,759
-25% -$55K ﹤0.01% 4121
2014
Q2 		$184K Sell
7,036
-1,410
-17% -$30.2K ﹤0.01% 4205
2014
Q1 		$221K Sell
8,446
-909
-10% -$24.4K ﹤0.01% 4230
2013
Q4 		$159K Buy
9,355
+4,855
+108% +$85.3K ﹤0.01% 4861
2013
Q3 		$97K Buy
+4,500
New +$78.2K ﹤0.01% 4746

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Citigroup's PTCT Position: Q2 2026 in Review

Citigroup increased its PTC Therapeutics (PTCT) stake by 436% in Q2 2026, buying an estimated $6.97M and bringing the position to 118,656 shares worth $9.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Citigroup first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $15.6M in Q1 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Citigroup held 118,656 shares of PTC Therapeutics worth $9.68M as of Q2 2026.
  • Citigroup bought 96,510 PTC Therapeutics shares in Q2 2026, an estimated $6.97M.
  • PTC Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1645 holding.
  • Citigroup first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
  • Citigroup's PTC Therapeutics position peaked at $15.6M in Q1 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.